Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2006-05-04

Clinical Trial Update: Tolerability of ALK Grass Tablet in Children [Phase 1]

View source ↗

Summary

Phase 1 tolerability study of ALK Grass Tablet in children is summarized; the update covers tolerability findings from the early trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALK Grass Tablet (grass pollen allergen tablet)

Snippet

Sponsor: ALK-Abelló A/S | Conditions: Allergy | Phase 1 | Status: COMPLETED